ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026)
ENDRA Life Sciences (NDRA) reported EPS (Basic) of -$1.09 for Q1 2026, up 41.4% year-over-year from -$0.77 in Q1 2025, and up 66.46% quarter-over-quarter from -$3.25 in Q4 2025.
ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of EPS (Basic) data on file, last reported at -$1.09 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.09, up 41.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.22 (up 76.63% YoY), and the FY2025 annual result was -$8.93, up 84.32% from the prior year.
- EPS (Basic) rose to -$1.09 in Q1 2026 per NDRA's latest filing, from -$3.25 in the prior quarter.
- Over five years, EPS (Basic) peaked at $25.2 in Q4 2024 and troughed at -$706.18 in Q3 2023.
- A 5-year average of -$72.41 and a median of -$1.37 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) sank 64739.52% in 2023, then soared 11087.51% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$1.14 in 2022, then soared by 79.84% to -$0.23 in 2023, then soared by 11087.51% to $25.2 in 2024, then plunged by 112.9% to -$3.25 in 2025, then jumped by 66.46% to -$1.09 in 2026.
- Business Quant data shows NDRA's EPS (Basic) at -$1.09 in Q1 2026, -$3.25 in Q4 2025, and -$2.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 4.44 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.50 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.20 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -0.60 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.63 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.88 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 8.35 |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | -1.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -3.25 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -6.78 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | 25.20 |
| Sep 30, 2024 | -9.54 |
| Jun 30, 2024 | -70.40 |
| Mar 31, 2024 | -449.58 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -706.18 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -1.14 |
| Sep 30, 2022 | -1.09 |
| Jun 30, 2022 | -1.37 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -5.35 |
| Sep 30, 2021 | -0.06 |
| Jun 30, 2021 | -0.08 |